Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder (PTSD) is a mental and behavioral disorder that develops after experiencing a traumatic event, manifesting through symptoms such as intrusive thoughts, flashbacks, sleep disturbances, avoidance behaviors, and emotional or physical dysregulation. These symptoms, which can appear immediately or years later, persist for over a month and increase the risk of suicide and self-harm.
Health Outcomes
- Activation of Stress Response Pathways
- Altered Brain Activity to Negative Emotional Stimuli
- Altered Catecholamine Level
- Altered Endocannabinoid System Function Due to Specific Strain
- Altered Neurobiological Markers
- Elevated Pulse Rate Under Stress
- Enhanced Autonomic Function
- Enhanced Autonomic Nervous System Activity
- Enhanced Parasympathetic Nervous System Activity
- Enhanced Serotonin Pathway Function
- Enhanced Stress Resistance
- Enhanced Threat Response Appropriateness
- Improved Antidepressant Response
- Improved Anxiety Symptoms
- Improved Behavioral Elements
- Improved Behavioral Health
- Improved Coping Strategies
- Improved Depressive Symptoms
- Improved Distress of Life Score
- Improved Emotional Behavior
- Improved Emotional Processing
- Improved Emotional State
- Improved Emotional Well-Being Quality of Life
- Improved Emotional Well-being
- Improved General Behavioral Scores
- Improved Global Clinical Impression
- Improved Global Improvement of Symptoms (Clinician-Rated)
- Improved Glucocorticoid Negative Feedback on the HPA Axis
- Improved HPA Axis Response
- Improved Heart Rate Variability
- Improved High-Frequency Power
- Improved Mental Health
- Improved Mood
- Improved Neuroendocrine Stress Markers
- Improved Neuropsychiatric Outcomes
- Improved Parasympathetic Activity
- Improved Perceived Mental Well-being
- Improved Positive Mood States
- Improved Psychological Distress
- Improved Psychological Status
- Improved Psychological Well-being
- Improved Psychological Wellbeing
- Improved Psychosocial Domain Score
- Improved Psychosocial Health-Related Quality of Life
- Improved Regulation of HPA Axis
- Improved Relaxation
- Improved Serotonin Metabolism
- Improved Sex Life
- Improved Sleep-Related Recovery in Participants with High Chronic Stress
- Improved Social Function
- Improved Socialization
- Improved Stress Management
- Improved Stress Response
- Improved Stress Tolerance
- Improved Stress-Related Psychiatric Health
- Improved Subjective Recovery
- Improved Sympathetic Tone
- Increased Attachment Gain
- Increased BDNF Levels in the Prefrontal Cortex
- Increased Brain-Derived Neurotrophic Factor Levels
- Increased Cortisol Levels
- Increased Heart Rate Response to Stress
- Increased Heart Rate Variability
- Increased Hypocapnic Hyperventilation Area Time
- Increased Insomnia
- Increased Irritability
- Increased Oxytocin Synthesis in the Hypothalamus
- Increased Serum BDNF Levels
- Increased Serum Serotonin Levels
- Increased Social Avoidance
- Increased Stress Biomarkers
- Increased Systemic GABA Levels
- Increased Treatment Responders
- Maintained Lower Salivary Cortisol Levels
- Maintained Positive Mood Under Stress
- Modulated HPA Axis
- No CYP1A2 or CYP3A4 Interaction
- No Change in Appetite Parameters
- No Reduction in Stress or Anxiety
- Normalized Cortisol Levels
- Normalized HPA Axis Activity
- Normalized Stress Response
- Reduced Abnormal Brain Plasticity Due to Stress
- Reduced Anger
- Reduced Anxiety
- Reduced Anxiety Responses
- Reduced Anxiety Scores
- Reduced Anxiety Symptoms
- Reduced Anxiety-Related Biomarkers
- Reduced Anxiety-Related Physiological Changes
- Reduced Anxiety-like Behavior
- Reduced Clinically Relevant Anxiety
- Reduced Corticosterone Levels
- Reduced Cortisol Levels
- Reduced DASS-21 Score
- Reduced Depression Scores at Follow-Up
- Reduced Depression Symptoms
- Reduced Depression and Anxiety Scores
- Reduced Disturbed Sleep Night
- Reduced Fecal Cortisol Levels
- Reduced Gut Bacteria Associated with Mental Illness
- Reduced HPA Axis Hyperactivity
- Reduced Heart Rate Variability
- Reduced Hippocampal Apoptosis
- Reduced Hyperactivity of the Hypothalamic-Pituitary-Adrenal Axis
- Reduced Incidence of Crying
- Reduced Insomnia
- Reduced Irritability
- Reduced Limbic System Reactivity
- Reduced Negative Emotional Responses
- Reduced Negative Mood States
- Reduced Occurrence of Major Depressive Disorder
- Reduced Perceived Stress
- Reduced Post-Exercise Cortisol Response
- Reduced Psychological Distress
- Reduced Psychological Score
- Reduced Psychopathology Symptoms
- Reduced Salivary Alpha-Amylase Activity
- Reduced Salivary Chromogranin A Levels
- Reduced Salivary Cortisol Levels Under Stress
- Reduced Salivary Serotonin Levels in Response to Stress
- Reduced Serum BDNF Levels
- Reduced Serum Cortisol Levels
- Reduced Sleep Duration
- Reduced Stress Biomarkers
- Reduced Stress Hormone Levels
- Reduced Stress Indicators
- Reduced Stress Levels
- Reduced Stress Markers
- Reduced Stress Response
- Reduced Stress Scores
- Reduced Stress-Induced Anxiety
- Reduced Stress-Induced Hyperpermeability
- Reduced Stress-Induced Reduction in Diurnal Temperature Amplitude
- Reduced Stress-Induced Sleep Disruption
- Reduced Stress-Related Discomfort
- Reduced Subjective Stress Levels
- Reduced Sympathetic Nerve Activity
- Reduced Symptom Severity
- Reduced Total Side Effects Incidence
- Reduced Urinary Free Cortisol Levels
- Reduced VIA Positivity
- Stabilized Cortisol Levels
- Stabilized Physiological Stress Markers
- Worsened Depression Score